Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease

scientific article

Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2893.2005.00674.X
P698PubMed publication ID16611186

P2093author name stringMurphy L
Van Thiel DH
Leone N
Kennedy M
Aziz S
Dhillon S
Aziz A
Li DS
P2860cites workA model to predict survival in patients with end-stage liver diseaseQ28199900
Epidemiology and prevention of hepatitis B.Q33964707
Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trialQ34065241
Implementation of vaccination in patients with cirrhosisQ34538854
Hepatitis C infection and the patient with end-stage renal diseaseQ34708264
De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impactQ41727379
Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of EfficacyQ42244325
Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virusQ42990302
Vaccination of patients with liver disease: who, when, and how.Q43434094
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.Q44072943
Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosisQ45735685
P433issue4
P921main subjectHepatitis B vaccineQ117749
chronic liver diseaseQ5113984
P304page(s)217-221
P577publication date2006-04-01
P1433published inJournal of Viral HepatitisQ15749962
P1476titleEfficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease
P478volume13

Reverse relations

cites work (P2860)
Q343900722013 IDSA clinical practice guideline for vaccination of the immunocompromised host
Q36569183Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes
Q45361123Efficacy of high-dose intra-dermal hepatitis B virus vaccine in previous vaccination non-responders with chronic liver disease
Q38306933Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine
Q34036643Hepatitis B vaccine by intradermal route in non responder patients: an update
Q58096862Impfung bei Virushepatitis
Q37807853Importance of Hepatitis Vaccination in Patients with Chronic Liver Disease
Q46121018Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.

Search more.